Navigation Links
Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL)
Date:4/26/2008

n innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com.

SCHERING-PLOUGH DISCLOSURE NOTICE: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the IDEAL study and the potential market for PEGINTRON and REBETOL. Forward-looking statements relate to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward-looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded, generic or over-the-counter competition, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Part I, Item 1A. "Risk Factors" in Schering-Plough's 2007 10-K/A.

Endnotes:

1 Pegasys and Copegus are registered trademarks of Hoffmann-La Roche Inc.

Please see the Pegasys and Copegus product inserts for information on

these products.'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
2. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
3. Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
4. Final Data From the SEISMIC Trial Suggest Safety, Efficacy of Autologous Stem- Cell Therapy for Treating Congestive Heart Failure
5. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
6. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
7. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
8. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
9. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
10. BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO
11. Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... , July 27, 2015  Array ... financial results for the fourth quarter and ... a conference call to discuss those results ... Chief Executive Officer will lead the call. ... Eastern TimeToll-Free:(844) 464-3927Toll:(765) 507-2598Pass Code: 68380312 Webcast, ...
(Date:7/27/2015)... July 20, 2015 Research and Markets ... the "D-dimer Testing Market - Global Industry ... 2014 - 2022" report to their offering. ... diagnostics market is one of the fastest growing ... to the improved health care awareness, preference of ...
(Date:7/27/2015)... DUBLIN , July 27, 2015 /PRNewswire/ ... has announced the addition of the ... Competitors And Opportunities: 2015-2020 Analysis And Forecasts" ... Comprehensive information and evaluation of the ... analysis of manufacturers, segmentation, product offerings, competitive ...
Breaking Medicine Technology:D-dimer Testing Market - Global Industry Analysis 2015 2D-dimer Testing Market - Global Industry Analysis 2015 3Global Wound Care Markets 2015-2020 - Traditonal, Advanced And Regenerative: Competitors And Opportunities 2
... INDIANAPOLIS, Oct. 11, 2011 Eli Lilly and ... due to the December 31 retirements of longtime senior leaders, ... whose Lilly career spans 36 years, has led Lilly Bio-Medicines ... Lilly spans 33 years, has led global manufacturing operations since ...
... 2011 MedPro Imaging, a premium provider of new and ... transducer repair capabilities to include GE E8/E9 transducers.  MedPro is ... probes for the GE E8/E9 ultrasound systems and has been ... care systems for the past six months. In ...
Cached Medicine Technology:Lilly Announces Changes in Senior Management 2Lilly Announces Changes in Senior Management 3Lilly Announces Changes in Senior Management 4MedPro Imaging to Repair GE E8/E9 Ultrasound Transducers 2
(Date:7/27/2015)... Princeton, NJ (PRWEB) , ... July 27, 2015 ... ... e-book entitled "Applying Data To Reduce Hospital Readmissions." , The Centers for Medicare ... underlying facility-level data used as part of their penalty calculation. Known as the ...
(Date:7/27/2015)... ... July 27, 2015 , ... Gary D. Breslow, MD, FACS, ... is Founder and Medical Director of The Breslow Center in Paramus, NJ, which offers ... body in Northern New Jersey. The Breslow Center also hosts a world-class medical ...
(Date:7/27/2015)... ... 27, 2015 , ... For a limited time, Huntington Beach dentist , ... is a great time to change up a look or to simply brighten a ... affect your self-esteem. Over time, the enamel coating can become worn and can expose ...
(Date:7/27/2015)... TN (PRWEB) , ... July 27, 2015 , ... According ... the infection rate of hepatitis C has increased in Tennessee stemming from intravenous drug ... users and medical professionals at risk for contracting communicable diseases including Hepatitis B and ...
(Date:7/27/2015)... ... 2015 , ... Hexagon Geospatial is pleased to introduce the ... your geospatial experience. These new light-weight applications cohesively combine data, workflows, and analytics. ... “Our world is more dynamic than it has ever been,” said Mladen Stojic, ...
Breaking Medicine News(10 mins):Health News:BESLER Consulting Publishes E-book Focused on Reducing Hospital Readmissions 2Health News:NJ Top Doc, Dr. Gary Breslow, has launched Zwivel; a New Online Cosmetic Consultation Service for Doctors and Patients 2Health News:Huntington Beach Cosmetic Dentist, Dr. Rassouli, is Now Offering a Summer Promotion on Zoom Whitening 2Health News:Huntington Beach Cosmetic Dentist, Dr. Rassouli, is Now Offering a Summer Promotion on Zoom Whitening 3Health News:Tennessee Sees an Increase in Hepatitis C Infections from Intravenous Heroin Use 2Health News:Tennessee Sees an Increase in Hepatitis C Infections from Intravenous Heroin Use 3Health News:Hexagon Geospatial Visualizes Stories with the Hexagon Smart M.App® 2Health News:Hexagon Geospatial Visualizes Stories with the Hexagon Smart M.App® 3
... 9 The Beryl Companies, the nation,s leading ... the year just concluded. In 2008, Beryl logged ... country, launched a new service offering, added new ... clients, and increased revenues by 17 percent. The ...
... and Working Mother Media Launch Program to Support Breastfeeding ... Working Families announced today that it has launched an ... mothers, especially those in hourly and lower-wage positions -- ... partnership with Abbott Nutrition, Working Mother Media and a ...
... Inc., the 5th largest,Blood Glucose Monitoring Company in the ... Administration for the GLUCOCARD(R) 01-mini Blood,Glucose Monitoring System. , ... coding, displays results in 7 seconds,requires a tiny 0.3 ... the same,affordable test strips as the downloadable GLUCOCARD(R) 01 ...
... Multiple Lasers in One Future-Proof PlatformPALO ALTO, Calif., ... the launch of the JOULE Aesthetic Laser ... into a single, slender system, JOULE offers aesthetic ... a simple path to future technologies and procedures ...
... Platform to Help Marshfield Healthcare Professionals Efficiently Deliver ... SAP AG (NYSE: SAP ... Clinic has selected the comprehensive SAP(R) BusinessObjects(TM) ... business intelligence (BI) system. Offering simple, intuitive BI ...
... Once-Daily Topical Agent With a Novel Mechanism of ... Higher Patient Share in the U.S. Than in ... ResourcesWALTHAM, Mass., Feb. 9 Decision Resources, one ... for pharmaceutical and healthcare issues, finds that high ...
Cached Medicine News:Health News:The Beryl Companies Adds Services, Clients for Record Year in 2008 2Health News:First-of-Its-Kind Program Aims to Reduce Primary Barrier to Breastfeeding for Hourly and Lower-Wage Working Mothers 2Health News:First-of-Its-Kind Program Aims to Reduce Primary Barrier to Breastfeeding for Hourly and Lower-Wage Working Mothers 3Health News:First-of-Its-Kind Program Aims to Reduce Primary Barrier to Breastfeeding for Hourly and Lower-Wage Working Mothers 4Health News:ARKRAY USA Receives FDA Clearance on GLUCOCARD(R) 01-mini Blood Glucose Monitoring System 2Health News:Sciton Unveils the JOULE Aesthetic Laser Platform for Physicians Battling the Economic Squeeze 2Health News:Sciton Unveils the JOULE Aesthetic Laser Platform for Physicians Battling the Economic Squeeze 3Health News:Sciton Unveils the JOULE Aesthetic Laser Platform for Physicians Battling the Economic Squeeze 4Health News:Marshfield Clinic Selects SAP(R) BusinessObjects(TM) Solutions to Improve Patient Treatment and Clinic Management 2Health News:Marshfield Clinic Selects SAP(R) BusinessObjects(TM) Solutions to Improve Patient Treatment and Clinic Management 3Health News:Marshfield Clinic Selects SAP(R) BusinessObjects(TM) Solutions to Improve Patient Treatment and Clinic Management 4Health News:Marshfield Clinic Selects SAP(R) BusinessObjects(TM) Solutions to Improve Patient Treatment and Clinic Management 5Health News:Marshfield Clinic Selects SAP(R) BusinessObjects(TM) Solutions to Improve Patient Treatment and Clinic Management 6Health News:High and Super-High Potency Topical Corticosteroids Will Remain Decision Resources' Clinical Gold Standard Through 2017 for the Treatment of Atopic Dermatitis 2
... The SYNCHRON CX5-S workstation ... electrolyte testing, targeted to the ... than 200 samples per day. ... the CX5-S is easy to ...
... the high-volume lab, the SYNCHRON LX4201 simplifies ... up to 2,880 tests per hour. By ... SYNCHRON LX4201 with broad menu, speed and ... come to expect from Beckman Coulter-innovative, reliable ...
... It takes powerful technology to ... safety, and still lower costs. ... LX20 PRO, offering features that ... any other chemistry analyzer, including ...
... the power of the LX2000 Series ... resources without compromising testing quality.Plus, when ... LX20 PRO, you get advanced features ... other chemistry analyzer, including closed tube ...
Medicine Products: